MOC04
The Role of Comorbidities in Comprehensive Healthcare Utilization Among Persons with Multiple Sclerosis.

Thursday, June 2, 2022
Prince George's Exhibit Hall (Gaylord National Resort & Convention Center)
Lindsay O Neto, MPH , Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT
Jennifer A Ruiz, DPT , Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT
Aaron P Turner, Ph.D. ABPP (RP) , Department of Rehabilitation Medicine, University of Washington, Seattle, WA, Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA
Jodie K Haselkorn, MD, MPH , Department of Epidemiology, University of Washington, Seattle, WA, Department of Rehabilitation Medicine, University of Washington, Seattle, WA, Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA
Elizabeth S Gromisch, PhD, MSCS , Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT
PDF


Background: Comorbid conditions in multiple sclerosis (MS) are prevalent and have been associated with adverse health outcomes. Understanding the role of comorbidities in healthcare utilization among persons with MS (PwMS) may help to determine if certain comorbidities may require greater attention in MS.

Objectives: To determine the association between comorbidities and 1) healthcare utilization and 2) perceived barriers to care.

Methods: Participants (n=185) were PwMS recruited from a comprehensive MS care center. Demographics, comorbidities, and disability level were collected. Participants were also asked if they had used a number of healthcare services over the prior 12 months and about their perceived barriers to care such as distance to medical facilities or lack of transportation. If differences were found between PwMS with and without a comorbidity, regression models were conducted to determine which comorbidity had a role in the difference, controlling for age, gender, race, education, and annual income.

Results: PwMS with a comorbidity had greater healthcare utilization, including a greater number of healthcare provider visits (p<0.001), number of unique healthcare providers seen (p<0.001), inpatient hospital stays (p=0.036), elective surgeries (p=0.034), MRI images (p=0.008), x-ray images (p=0.017), and current medications taken (p<0.001). Several comorbidities, including sleep apnea, anxiety, and irritable bowel syndrome, were most frequently associated with increased healthcare use. There was no difference in perceived barriers to care between groups.

Conclusions: While no differences in perceived barriers to care were observed, PwMS with comorbidities had more healthcare utilization in the prior 12 months, with several comorbidities having a role in increased healthcare utilization. These findings suggest that PwMS with comorbid sleep apnea, anxiety, and irritable bowel syndrome may require more attention in the management of their conditions.